Drug Information Analysis Service

Scheinhorn D. J. Angelillo V. A. : Antituberculous Therapy in Pregnancy, West J. Med. 127: 195–198 (Sept.) 1977.

Nishimura H. Tanimura T. : Clinical Aspects of the Teratogenicity of Drugs, 1st Ed., American Elsevier Publishing Co., Inc., New York, N.Y. 10017, pp. 129–131, 135–140, 1976.

Bobrowitz I. D. : Ethambutol in Legnancy, Chest 66: 20–24 (July) 1977.

Davis J. L. : Peripheral Diabetic Neuropathy Treated with Amitriptyline and Fluphenazine, J. Am. Med. Assoc. 238: 2291–2292 (Nov. 21) 1977.

Ellenberg M. : Treatment of Diabetic Neuropathy With Diphenylhvdantoin. N.Y. State J. Med. 68: 2653–2655 (Oct.-Dec.) 1968.

Rull J. A. : Symptomatic Treatment of Peripheral Neuropathy With Carbamazepine (Tegretol®): Double-blind Crossover Trial, Diabetologia 5: 215–218, 1969.

Saudek C. D. : Phenytoin in the Treatment of Diabetic Symmetrical Polyneuropathy, Clin. Pharmacol. Ther. 22: 196–199 (Aug.) 1977.

Reddy P. S. : The Adverse Effect of IV Iron-Dextran in Rheumatoid Arthritis, Arth. Rheum. 12: 454–457 (Aug.) 1969.

Lloyd K. N. : Reactions to Total Dose Infusion of Iron-Dextran in Rheumatoid Arthritis, Br. Med. J. 1: 323–325 (May 9) 1970.

Jones C.E. : Total Dose Infusion of Iron-Dextran in Rheumatoid Arthritis, Rheumatol. Phys. Med. 11: 240–245 (Feb.) 1972.

West W. O. : Specific Indications For Parenteral Iron Therapy — Experience With One Hundred Patients Using Intravenous Iron-Dextran, Kentucky Med. Assoc. 72: 604–608 (Nov.) 1974.

Wintrobe M. M. : Iron-Deficiency Anemia and Other Hypochromic Microcytic Anemias, In Wintrobe M. M. : Harrison's Principles of Internal Medicine, McGraw-Hill Book Co., New York, p. 1594, 1974.